approached significancep = 0.06
The MVX scores approached significance with a value of 57.2 ± 10.1 in patients on tacrolimus compared to 50.9 ± 7.9 in patients on cyclosporine (p = 0.06).
The MVX scores approached significance with a value of 57.2 ± 10.1 in patients on tacrolimus compared to 50.9 ± 7.9 in patients on cyclosporine (p = 0.06).
While MVX and IVX were similar in obese and non-obese patients, a trend towards a lower MMX value was noted in obese LT recipients, however, this did not reach statistical significance (57.7 ± 8.5 vs. 59.9 ± 7.8; p = 0.07).